The European Commission, EC, has rejected Emotra’s application, submitted in January 2017, for approximately 3 MEUR, intended for three purposes: First of all to finance EUDOR-Y, a clinical multi-centre study on young people, secondly to develop EDOR® Interconnect,...
The Board and CEO of Emotra AB herewith present the year-end report for the financial year 2016. 170215 - Year-end report 2016
Emotra has submitted a new application to the European Commission (EC) for Horizon 2020 funding assistance. The Company’s previous application, which we submitted in October 2016, cleared the threshold by a wide margin and was awarded a “Seal of Excellence” by the EC....
On November 28, Emotra announced that the Company’s Horizon 2020 application to the European Commission has been rejected. We have now had the opportunity to review the EC’s statement and we see that our application passed their threshold by a wide margin and that it...
The European Commission has rejected Emotra’s application for approximately 3 MEUR, which we intended to use for three purposes: First of all to finance EUDOR-Y, a clinical multi-centre study on young people, secondly to develop EDOR® Interconnect, and thirdly to...
Emotra’s Board of Directors has decided the following dates for release of financial reports and the annual shareholder meeting 161128-emotra-nyhetsbrev-dates-for-financial-reports-en
Last week in Chicago, Lars-Håkan Thorell, the inventor of EDOR® and the Company’s Head of research, held a presentation that gathered a great deal of attention. He presented the result of his research and how it led to the development of EDOR®....
The Board of Directors and the CEO of Emotra AB (publ) hereby present the interim report for the first nine months of the financial year 2016. 161026-interim-report-jan-sept-2016
This past week Lars-Håkan Thorell, the inventor of EDOR® and Emotra’s Head of research, has received a great deal of attention for his many years of research into identifying patients who are at risk of committing suicide. Thorell has been voted in as a member of the...
During the past few days, on September 8–11, Emotra participated in the 16th European Symposium on Suicide and Suicidal Behaviour, ESSSB, in Oviedo, Spain. New, exciting studies on EDOR® were presented by research groups from Oviedo and Novara. ...
